We have previously demonstrated that the anti-apoptotic activity of endogenous Mcl-1 is essential to maintain the survival of murine BCR-ABL-expressing B-lineage acute lymphoblastic leukemia (B-ALL) cell lines despite the concomitant expression of other anti-apoptotic molecules [10]. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.